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Abstract. The transition from metaphase to anaphase 
is regulated by a checkpoint system that prevents chro- 
mosome segregation in anaphase until all the chromo- 
somes have aligned at the metaphase plate. We provide 
evidence indicating that a kinetochore phosphoepitope 
plays a role in this checkpoint pathway. The 3F3/2 mono- 
clonal antibody recognizes a kinetochore phosphoepi- 
tope in mammalian cells that is expressed on chromo- 
somes before their congression to the metaphase plate. 
Once chromosomes are aligned, expression is lost and 
cells enter anaphase shortly thereafter. When microin- 
jected into prophase cells, the 3F3/2 antibody caused a 
concentration-dependent delay in the onset of ana- 
phase. Injected antibody inhibited the normal dephos- 
phorylation of the 3F3/2 phosphoepitope at kineto- 
chores. Microinjection of the antibody eliminated the 
asymmetric expression of the phosphoepitope normally 
seen on sister kinetochores of chromosomes during 
their movement to the metaphase plate. Chromosome 
movement to the metaphase plate appeared unaffected 
in cells injected with the antibody suggesting that asym- 
metric expression of the phosphoepitope on sister 
kinetochores is not required for chromosome congres- 
sion to the metaphase plate. In antibody-injected cells, 
the epitope remained expressed at kinetochores 
throughout the prolonged metaphase, but had disap- 
peared by the onset of anaphase. When normal cells in 
metaphase, lacking the epitope at kinetochores, were 
treated with agents that perturb microtubules, the 
3F3/2 phosphoepitope quickly reappeared at kineto- 
chores. Immunoelectron microscopy revealed that the 
3F3/2 epitope is concentrated in the middle electron- 
lucent layer of the trilaminar kinetochore structure. We 
propose that the 3F3/2 kinetochore phosphoepitope is 
involved in detecting stable kinetochore-microtubule 
attachment or is a signaling component of the check- 
point pathway regulating the metaphase to anaphase 
transition. 
I 
N meiotic and mitotic cells, the failure of a single chro- 
mosome to align properly at the metaphase plate acti- 
vates a cell cycle checkpoint mechanism that inhibits, 
at least temporarily, anaphase onset and further progres- 
sion of the cell cycle (reviewed in 9, 21). A quarter century 
ago, Zirkle, in a widely disseminated abstract (Zirkle, R. E. 
1970. J.  Cell Biol.  47:235a),  proposed that  kinetochores 
were  involved  in  signaling  the  presence  of  misaligned 
chromosomes.  Mclntosh  (19)  suggested  that  the  cen- 
tromere/kinetochore regions of unattached chromosomes 
emit a signal that prevents premature anaphase onset. He 
speculated that  this  signal  was turned off in response to 
tension applied to the centromere/kinetochore region by 
stable attachment of sister kinetochores to spindle micro- 
tubules.  Recently, Li and  Nicklas  (16)  have shown that 
tension  applied  artificially  with  a  microneedle  to  mis- 
aligned  chromosomes in mantid  spermatocytes can  turn 
off  the  checkpoint  signal  and  allow  progression  to 
anaphase. 
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Early embryos appear to rely more on rigid  timing  of 
the  cell cycle and  appear  less  responsive to checkpoint 
controls (29). Minshull and Murray (20) found that cycling 
extracts from activated Xenopus eggs could be blocked in 
M phase with microtubule inhibitor only in the presence of 
a large number of chromosomes, again implicating  a con- 
nection between kinetochores  or something  else on the 
chromosomes  and  the  checkpoint  control  that  inhibits 
anaphase  onset  if  spindle  assembly  and  chromosome 
alignment are defective. 
The biochemical mechanisms  underlying the ability of 
cells to detect and react to misaligned chromosomes have 
yet  to  be  elucidated.  Budding  yeast  possess  a  mitotic 
checkpoint that is activated in response to abnormal kinet- 
ochore-microtubule interactions  (22,  30).  Yeast mutants 
termed mad (mitotic arrest  deficient) and bub  (budding 
uninhibited by benzimidazole) have been selected that are 
faulty in their ability to arrest in mitosis when treated with 
microtubule inhibitor (11, 15). A possible complication is 
that  cells  may possess multiple  checkpoints in M  phase. 
For example, one checkpoint system may assess the  as- 
sembly of the mitotic spindle microtubules while a differ- 
ent pathway may monitor the attachment and alignment 
of the chromosomes. Alternatively, since spindle disrup- 
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chromosomes, it is possible that both arrests come about 
through the same mechanism. Biochemically, kinetochore 
components are best characterized in budding yeast and 
include a 58-kD protein for which there exists a tempera- 
ture sensitive mutant allele (ctf13-30) that causes a tempo- 
rary cell cycle arrest at the G2/M stage (see 13 for a re- 
view). 
Several lines of evidence suggest that dephosphoryla- 
tion events are essential for overcoming this checkpoint. 
Certain  mutants  in  fungi  and  Drosophila with  altered 
phosphatase activity result in a  metaphase arrest pheno- 
type (17, 24). The activated Xenopus egg extracts arrested 
by the addition of chromosomes and microtubule inhibitor 
are released from the block by the addition of a specific 
phosphatase  that dephosphorylates and thus deactivates 
MAP kinase (20). Mammalian cells, when treated with the 
general  kinase  inhibitor  2-aminopurine,  escape  mitotic 
arrest  induced with microtubule  inhibitors  (1).  In  cells 
treated with the phosphatase inhibitor okadaic acid, mi- 
totic chromosomes undergo asynchronous entry into ana- 
phase (14). 
Recently, Rieder et al. (26) analyzed the timing of ana- 
phase onset in Ptkl cells, a mammalian tissue culture line. 
They found that anaphase onset ensues on average 23 rain 
after bipolar attachment of the final chromosome to the 
mitotic spindle. Using a monoclonal anti-phosphoepitope 
antibody prepared by Cyert et al. (6) and designated 3F3/2, 
Gorbsky and Ricketts (10)  identified within Ptkl cells a 
phosphorylation difference among chromosomes at differ- 
ent stages of congression to the metaphase plate. Those 
chromosomes that had fully congressed to the metaphase 
plate showed no expression of the phosphoepitope recog- 
nized by the  antibody while  those  some  distance  from 
alignment showed strong expression. The kinetochores of 
"lost" chromosomes, unattached to the mitotic spindle, ex- 
hibited particularly strong expression. The epitope was also 
expressed on the leading kinetochore of a  chromosome 
congressing to the metaphase plate, but not the trailing one. 
They presented two hypotheses: (a) that the kinetochore 
phosphoepitope is involved in a  checkpoint that inhibits 
anaphase  onset  in  the  presence  of misaligned  chromo- 
somes, and (b) that the 3F3/2 kinetochore epitope regu- 
lates chromosome movement along spindle microtubules. 
To test these hypotheses, we microinjected the 3F3/2 
monoclonal antibody into  prophase  Ptkl  cells  and  ob- 
served subsequent mitotic events. We found that the anti- 
body caused a concentration-dependent delay of anaphase 
onset. The antibody appeared to have no effect on chro- 
mosome movement. We propose  that the 3F3/2  kineto- 
chore phosphoepitope is involved in a checkpoint pathway 
that monitors chromosome attachment to and alignment 
on the mitotic spindle. This checkpoint delays anaphase 
until  all  chromosomes  have  aligned  at  the  metaphase 
plate, thus preventing the generation of progeny cells with 
an abnormal complement of chromosomes. 
Materials and Methods 
Cell Culture 
Ptkl cells were cultured in Ham's F12 medium (GIBCO BRL, Gaithers- 
burg, MD) supplemented with 5% FBS (Hyclone Laboratories, Inc., Lo- 
gan, UT), 5% Nu-serum (Collaborative Research, Bedford, MA), 20 mM 
Hepes, and 60 ~g/ml penicillin and 100 ~,g/ml streptomycin. Ceils for live 
observations and mieroinjeetions were grown on coverslips sealed with sil- 
icone grease over holes in the bottoms of 35-ram culture dishes. These 
chambers were sterilized by UV irradiation. A diamond scribe was used to 
form a simple pattern on the coverslips to aid relocation of experimental 
ceils. 
Live Cell Observations and Microinjections 
Culture dishes were placed on the warmed stage of a Nikon Diaphot mi- 
croscope. Temperature of the medium was maintained at 34 _+ 1°C with a 
warmed air curtain incubator (Sage, Boston, MA). The medium in the 
dish was overlaid with mineral oil to slow evaporation. 
For live cell observations, a Nikon 40x objective was used with a long 
working distance condenser and charge-coupled device camera (Dage- 
MTI, Michigan City, IN). Images were processed using the contrast en- 
hancement and averaging functions of Image-1 software (Universal Imag- 
ing, West Chester, PA). Video recordings were made with an extended 
definition beta video cassette recorder (Sony, Cypress, CA). 
For injection, the 3F3/2 and MPM-2 antibodies were purified from as- 
cites fluid on a  protein A-Sepharose column. They were then concen- 
trated and exchanged into microinjection buffer (0.8% KC1, 0.01% NaCI, 
0.115%  Na2HPO  4,  0.02%  KH2PO4)  with  a  Centricon-30 concentrator 
(Amicon, Beverly, MA). Antibody concentrations were determined with 
the BCA assay (Pierce Chem. Co., Rockford, IL). All injected solutions 
were filtered to 0.2 ~m. Injections were performed with a micromanipula- 
tor (Narishige USA, Inc., Sea Cliff, New York), and ceils were injected to 
5% of cell volume. 
In experiments in which nocodazole and taxol were used, cells in dishes 
containing one ml of medium were observed until the desired stage of mi- 
tosis. 1 ml of medium containing twice the desired final concentration of 
drug was then added. Nocodazole (Sigma Immunochemicals, St. Louis, 
MO) was used at a final concentration of 1.25 ixg/ml. Taxol (provided by 
Dr. Matthew Suffness at the National Cancer Institute) was used at 50 ~M. 
Cell Fixation and Immunofluorescence 
All manipulations were performed at room temperature. Cells on cover- 
slips were rinsed briefly with 60 mM PIPES, 25 mM Hepes, pH 6.9,10 mM 
EGTA, and 4  mM MgC12 (PHEM) t  and extracted  for  5  min in 0.5% 
CHAPS detergent in PHEM with 100 nM microcystin LR (Calbiochem 
Novabiochem, San Diego, CA). In some experiments, as noted, microcys- 
tin was not included in the lysis buffer. Fixation was for 15 rain in 1% 
paraformaldehyde in PHEM followed by rinsing in 10 mM MOPS, pH 7.4, 
150 mM NaC1, 0.05% Tween-20 (MBST). 
Before immunolabeling, coverslips were blocked for 20 rain in 20% 
boiled normal goat serum (NGS) in 10 mM MOPS, pH 7.4, 150 mM NaCI 
(MBS). 3F3/2 antibody ascites was used at a 1/4,000 dilution in 5% NGS in 
MBS. A  CREST human autoimmune serum (a gift of J. B. Rattner, Uni- 
versity of Calgary) was used in some experiments at a 1/500 dilution to la- 
bel kinetochores. Rabbit anti-tubulin serum was used at a 1/1,000 dilution 
to label microtubules. Coverslips were incubated in primary antibodies for 
I h, rinsed 10 min in four changes of MBST, incubated 30 min in Cy3-con- 
jugated  goat  anti-mouse IgG  (Jackson  Immunoresearch Laboratories, 
West Grove, PA) at 1/400  and, to visualize CREST or anti-tubulin anti- 
bodies when present,  fluorescein-conjugated goat  anti-human or  anti- 
rabbit IgG (Pierce) at 1/200, and rinsed again. Cells that had been injected 
with 3F3/2 were treated identically except there was no 3F3/2 in the pri- 
mary incubation,  Coverslips were  rinsed in  the DNA  labels Yo-Pro-1 
(Molecular Probes, Inc., Eugene, OR) at 0.2 ~M or DAPI (Sigma) at 0.5 
jzg/ml in water before mounting in Vectashield (Vector Labs., Inc., Bur- 
lingame, CA) with 10 mM MgCI2 to help preserve chromatin structure. 
Fluorescently labeled cells were imaged either with a Nikon Diaphot 
equipped with a 60× 1.4 NA objective, image intensifier and CCD camera 
(DAGE-MTI) or a  Zeiss LSM 410 confocal microscope with a  63×  1.4 
NA objective. Images for publication were taken with a film recorder (Fo- 
cus Graphics, Foster City, CA). 
1. Abbreviations used in this paper: MBS, 10 mM MOPS, pH 7.4, 150 mM 
NaC1;  MBST, 10 mM MOPS, pH 7.4,  150 mM NaCI, 0.05% Tween-20; 
NGS, normal goat serum; PHEM, 60 mM PIPES, 26 mM Hepes, pH 6.9, 
10 mM EGTA, and 4 mM MgCI  2. 
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To establish a baseline for testing the effects of microinjected 3F3/2 anti- 
body, normal, uninjected cells were observed to determine the timing of 
mitotic events.' Prometaphase was defined as starting with the first evi- 
dence of nuclear envelope breakdown. Because no similar morphological 
event clearly signifies the start of metaphase, we used our own working 
definition. Using Image-1 software, we superimposed a  rectangular box 
extending 3 p,m on either side of the midplane of the spindle. We defmed 
the beginning of metaphase as the time at which all the kinetochore re- 
gions of the chromosomes were within the box, in other words within 3 p,  rn 
of the spindle equator (Fig. 1 A). This moment correlated well with the 
point at which 3F3/2 labeling is no longer seen at the kinetochores (Fig. 1, 
B  and C). For comparison, the length of the spindle ranges from ~13-16 
p,m measured in cells labeled with 3F3/2, which also binds to centrosomes. 
Anaphase onset was defined as the first evidence of sister chromatid sepa- 
ration as seen with phase contrast microscopy. 
Mean metaphase transit times for different experimental treatments 
were compared by one way analysis of variance and Tukey's range test. 
Significant differences were determined at 95% or greater probability. 
Immunoelectron Microscopy and Analysis 
To accumulate mitotic cells, cultures were blocked 4 h with 4.5 p,g/ml vin- 
blastine (Sigma). Cells grown on coverslips were rinsed with PHEM and 
treated 1 rain with 0.5% CHAPS in PHEM with 100 nM microcystin LR. 
An equal volume of 1%  glutaraldehyde in PHEM was then added and 
cells were incubated for 10 more min. Free aldehyde groups were quenched 
by treatment for 15 min in 10 mg/ml NaBH2 in water.  Immunolabeling 
was carded out as described above through the incubation in 3F3/2 pri- 
mary antibody. Secondary incubation was for  1  h  in Nanogold  1.4 nm 
gold-conjugated goat anti-mouse F(ab') (Nanoprobes, Stony Brook, NY) 
at a dilution of 1/25. Samples were then postfixed 10 min in 2% glutaralde- 
hyde in MBS, rinsed in MBST and then water for 25 min, followed by sil- 
ver enhancement for 5 min as described in detail by Burry et al. (4). After 
enhancement, coverslips were rinsed several times in water, incubated 15 
min in 0.2%  tannic acid, rinsed in water, and stained in 0.14%  osmium 
tetroxide,  0.6%  uranyl  acetate  for  15  min.  Samples were  dehydrated 
through a  graded  series of ethanols,  infiltrated,  and  flat  embedded in 
EPON. Hardened blocks were examined by light microscopy and mitotic 
cells were selected and marked for sectioning. Samples were  examined 
and photographed in a JEOL 100CXII electron microscope. 
The distribution of silver particles on electron micrographs was deter- 
mined with Image-1 software (Universal Imaging Corp., West Chester, 
PA). Tracings were made on 10 images of kinetochores to divide them 
into three regions corresponding to the electron-lucent middle zone be- 
tween the inner and outer plates, generally 20--25 nm wide, the outer plate 
and fibrous corona, extending 100-140 nm above the middle zone, and the 
inner plate  and underlying chromatin extending ~150 nm beneath the 
middle zone. The middle zone was demarcated where a 40%  or greater 
change in pixel intensity occurred upon scanning outward from the inner 
plate to the middle zone and inward from the outer plate to the middle 
zone. Since many particles overlapped, a  mean particle size of 100 nm  2 
was assigned based on clear single particles, and particles smaller than 50 
nm  2 were not included in measurements. With the Image-1 software we 
then calculated the number of particles within each region. A particle was 
included in a region if its centroid (center of mass) lay within that region. 
Results 
Microinjected 3F312 Binds Rapidly to Kinetochores 
To determine whether the injected  antibody  would bind 
readily to kinetochores in living cells, the antibody was in- 
jected into the nuclei of prophase  cells or into the cyto- 
plasm of prometaphase  cells. The cells were immediately 
removed from the microscope stage,  detergent extracted, 
fixed, and treated  with fluorescent secondary  antibodies. 
The time between injection  and extraction  was ~12 s. As 
shown in Fig. 2 (A  and B), injected  antibody  specifically 
bound to kinetochores within this short time. To eliminate 
the possibility  of antibody  binding  during the extraction, 
other cells were fixed before detergent extraction. Kineto- 
chores in cells so treated  were clearly  labeled, although 
higher background  staining  was seen, presumably  due to 
unbound antibody in the cytoplasm  (Fig. 2, C and D). 
Microinjection of 3F312 Antibody Delays 
Anaphase Onset 
To learn whether binding  of the 3F3/2  antibody  in living 
cells would perturb mitotic events, antibody  was microin- 
jected into the nuclei of early to mid-prophase  Ptkl cells 
and subsequent  events were observed.  Nuclear envelope 
breakdown,  prometaphase  chromosome movement,  and 
metaphase  alignment  appeared  normal.  However, micro- 
injection with 3F3/2 antibody significantly prolonged meta- 
phase in comparison  to control cells (Table  I). The length 
of the delay of anaphase  onset increased  in proportion to 
the concentration  of antibody  injected.  The longest times 
spent in metaphase,  after injection  with 3F3/2 antibody  at 
11 mg/ml in the micropipette,  ranged  from 44 to 91 min, 
compared  to ~11 min in a comparable  untreated  cell. A 
second  batch  of more  recently  purified  3F3/2  antibody 
consistently  caused even longer delays in metaphase,  up to 
135  rain, when injected  at  11  mg/ml.  Cells injected  with 
Figure 1.  Definition of the start of metaphase. A  Ptkl  cell was extracted  and fixed when kinetochore regions of chromosomes were 
within a box extending 3  ~,m on either side of the spindle midplane when observed by phase contrast microscopy (A). The same cell was 
then immunolabeled with CREST  serum (B), which labels kinetochores at all stages of the cell cycle, and 3F3/2 antibody (C), which la- 
bels kinetochores only before metaphase. The 3F3/2 antibody also labels centrosomes through late  anaphase, but they are out of the 
plane of focus in C. Bar, 5  ixm. 
Campbell and Gorbsky 3F3/2  Antibody Delays  Anaphase  1197 Figure 2.  Microinjected 3F3/2 antibody binds rapidly to kinetochores. Immediately after injection with 3F3/2 antibody, cells were 
quickly rinsed in PHEM and either extracted with detergent then fixed (A and B), or fixed and then extracted with detergent (C and D). 
Cells were then treated with fluorescent anti-mouse IgG secondary antibodies to visualize injected 3F3/2 antibody (B and D) and Yo- 
Prol to label chromosomes (A and C). C and D are confocal micrographs. Bars, 5 p.m. 
Table I. Minutes Spent in Metaphase by Cells 
Microinjected with 3F3/2 Antibody 
Injection  Average  (SD)  Range  Number  of cells 
None  10.4 (4.4)*  6.5-17.5  10 
Buffer  14.7 (5.4)*  9.5-22  5 
Boiled 3F3/2 11 mg/ml  14.9 (4.5)*  10-21  5 
MPM-2 11 mg/ml  10.9 (3.8)*  4.5-15.5  9 
3F3/2 5.5 mg/ml  31.9  (7.7):~  19-43  5 
3F3/2 11 mg/ml  65.4  (13.8)§  44-91  13 
* Not significantly  different  from  each  other. 
:~ Significantly  different  from  other  values,  P < 0.05. 
§ Significantly  different  from  other  values,  P < 0.01. 
3F3/2 antibody eventually entered anaphase after the de- 
lay and completed cytokinesis normally. Fig. 3 shows a cell 
injected with 3F3/2 at 11 mg/ml from postinj  ection through 
anaphase. Control cells included those receiving no micro- 
injection, injection with buffer alone, with 3F3/2 antibody 
that had been boiled for 10 min, and with the MPM-2 anti- 
body, which has also been shown to bind to kinetochores 
by immunofluorescence  and immunoelectron microscopy 
(31,  33,  34).  Cells  injected  with  MPM-2  antibody fixed, 
and labeled with  fluorescent secondary antibody showed 
strong labeling of kinetochores (not shown). No effects on 
chromosome movement or the progression of mitosis were 
noted in control cells. 
Microinjected Antibody Inhibits Dephosphorylation 
of the 3F312 Phosphoepitope 
To  understand  the  mechanism  by  which  microinjected 
3F3/2  antibody  delayed  anaphase  onset,  we  determined 
the  status  of the  phosphoepitope  in  injected cells.  Nor- 
mally, at metaphase, when  all chromosomes are properly 
aligned,  the  epitope  is  no  longer  expressed  at  kineto- 
Figure 3.  Microinjected 3F3/2 antibody delays anaphase onset. Phase contrast images of a cell injected with 3F3/2 antibody at 11 mg/ml 
at 0 min. 2 min later (A), the cell was still in prophase. NEB occurred at 7 min and (B) shows the cell at 9 min. Metaphase was reached 
at 20.5 min (C) and the cell was still in metaphase at 62 min (D). Anaphase onset occurred at 93.5 min and (E) shows the cell at 94.5 min. 
By 103 min (F) the cell reached late telophase and went on to complete a normal cytokinesis. Prometaphase lasted 13.5 min, comparable 
to untreated cells in which it is very variable but generally lasts 10-30 min. Metaphase lasted 73 min, compared to 10-13 min in un- 
treated cells. Bar, 5 p~m. 
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After injection with 3F3/2 antibody, cells were allowed to progress to metaphase  (A and B) or early anaphase (C and D) and were then 
extracted, fixed, and labeled with fluorescent anti-mouse secondary antibodies  (B and D). Fluorescent  images of chromosomes  are 
shown in A and C. One centrosome is faintly visible in D; the other is in a different plane of focus. A and B are confocal micrographs. 
Bar, 5 txm. 
chores. Cells injected with 3F3/2 antibody were allowed to 
reach metaphase and then were extracted, fixed, and la- 
beled with fluorescent secondary antibody. The 3F3/2 phos- 
phoepitope  was  expressed  at  the  kinetochores  of meta- 
phase  chromosomes in  injected  ceils  (Fig.  4,  A  and  B). 
However, once the 3F3/2 antibody-injected cells started ana- 
phase, the epitope was no longer expressed at the kineto- 
chores of the anaphase chromosomes (Fig. 4, C and D). 
Differential Expression of the Phosphoepitope on 
Sister Kinetochores Is Not Essential  for Directed 
Chromosome Movement Toward the Metaphase Plate 
Based on the asymmetric immunolabeling of sister kineto- 
chores in chromosomes congressing toward the metaphase 
plate, Gorbsky and Ricketts (10) postulated a role for the 
3F3/2  phosphoepitope in  regulating  chromosome move- 
ment in prometaphase. However, as noted, prometaphase 
chromosome movements appeared unimpaired in cells mi- 
croinjected with  3F3/2  antibody.  Moreover, in  microin- 
jected  cells  fixed  during  chromosome  congression  in 
prometaphase, expression of the phosphoepitope was in- 
variably equal on both kinetochores of each chromosome. 
Chromosomes  actively  moving  toward  the  metaphase 
plate were brightly labeled on both kinetochores (Fig. 5). 
Thus,  asymmetric expression of the  phosphoepitope  on 
sister kinetochores of a single chromosome is not essential 
for movement of chromosomes to the metaphase plate. 
3F312 Antibody Preserves the 
Phosphoepitope During Cell Extraction in the 
Absence of  Phosphatase Inhibitors 
The kinetochore phosphoepitope recognized by the 3F3/2 
antibody is very labile and normally is preserved for im- 
munofluorescence labeling  only when  the  potent  phos- 
phatase inhibitor microcystin LR is included in the extrac- 
tion buffer (10). To determine if microinjected antibody 
alone could preserve the epitope by inhibiting phospha- 
tase activity, injected cells that had reached prometaphase 
were extracted in the absence of microcystin, fixed, and la- 
beled with fluorescent secondary antibody. As seen in Fig. 
6, in the microinjected cells the 3F3/2 antibody remained 
bound at the kinetochores in the absence of phosphatase 
inhibitor, suggesting that the presence of the antibody pro- 
tected the phosphoepitope from dephosphorylation by en- 
dogenous phosphatases. 
Microtubule Perturbations Affect Expression of the 
3F312 Kinetochore Phosphoepitope 
Agents that promote disassembly of microtubules and dis- 
turb spindle organization delay cells in mitosis (reviewed 
in 25). Since the continued expression of the 3F3/2 epitope 
on kinetochores was correlated with the delay of anaphase 
onset in injected cells, it was of interest to investigate the 
effects of microtubule-disrupting agents on the expression 
of the 3F3/2 phosphoepitope. 
Ptkl cells were observed until early metaphase, by which 
point the kinetochores have lost expression of the 3F3/2 
phosphoepitope. Nocodazole was  added  to  the  medium 
for various lengths of time, and the cells were prepared for 
immunofluorescence  labeling  with  3F3/2  antibody.  We 
found that the 3F3/2 phosphoepitope reappeared at the ki- 
netochores of metaphase  chromosomes  in  ceils  treated 
with nocodazole. Expression was first detectable by immu- 
nofluorescence labeling after only 3 min of incubation in 
nocodazole and was maximal at 5 min (Fig. 7, A  and B). 
At these times, anti-tubulin immunofluorescence showed 
that  kinetochore fiber bundles  extending from the  cen- 
Figure 5.  Microinjection of 3F3/2 antibody eliminates differential 
expression of the 3F3/2 phosphoepitope between sister kineto- 
chores. This cell was injected in prophase and prepared for im- 
munofluorescence in late prometaphase as the indicated chromo- 
some (arrow) was approaching  the metaphase  plate.  3F3/2 (B) 
was visualized with fluorescent  secondary  antibodies  and chro- 
mosomes (A) with Yo-Prol on a confocal microscope. Bar, 5 Ixm. 
Campbell and Gorbsky  3F3/2  Antibody  Delays  Anaphase  1199 Figure 6.  The 3F3/2 antibody protects the phosphoepitope from dephosphorylation. Control uninjected (A and B) and 3F3/2 injected (C 
and D) cells were extracted in buffer without microcystin and then fixed. The uninjected cell was then labeled with 3F3/2 antibody and 
fluorescent anti-mouse secondary antibodies (B), and the injected cell with secondary antibodies only (D). The larger labeled spots in D 
are not kinetochores, but unidentified nuclear structures typically labeled in interphase and early prophase cells. Fluorescently labeled 
chromosomes are shown in A and C. Bar, 5 p.m. 
trosomes to the kinetochores had not yet been disrupted 
(Fig. 7  C).  Cells  at various later  times  in metaphase  and 
cells that had progressed into anaphase  were also tested. 
After a 12-min incubation in nocodazole, the cells were ex- 
tracted, fixed, and immunolabeled with 3F3/2 antibody. As 
seen in Fig. 7, D-G, nocodazole treatment leads to the re- 
appearance of the 3F3/2 phosphoepitope on kinetochores 
when  applied  throughout  metaphase,  but  not  after  ana- 
phase has begun. 
The  drug taxol promotes  the  stability  and  assembly of 
microtubules,  and  has  also  been  shown  to  delay cells  in 
metaphase  (7, 26).  Cells in early metaphase  were treated 
with 50 ~m taxol for 12 min. As seen in Fig. 8, A  and B, 
taxol also caused the reappearance of the 3F3/2 phospho- 
epitope on the kinetochores of metaphase  chromosomes. 
Again, kinetochore microtubules were still present (Fig. 8 C). 
Ultrastructural Localization of the 3F312 
Kinetochore Phosphoepitope 
To  determine  the  precise  ultrastructural  location  of the 
Figure 7.  Nocodazole causes regeneration of the 3F3/2 kinetochore phosphoepitope during metaphase but not anaphase. (A-C) 2 min 
after chromosomes reached the metaphase plate (early metaphase) the cell was treated with nocodazole for 5 min and labeled for DNA 
(A), 3F3/2  (B),  and microtubules (C). (D-G) A  cell  was treated with nocodazole for 12 min beginning 12 min after the start  of 
metaphase (late metaphase) (D and E) or shortly after the start of anaphase (F and G). The 3F3/2 phosphoepitope can be regenerated 
well into metaphase (E), but not after anaphase has begun (G). A-C are confocal micrographs. Bar, 5 tzm. 
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and labeled for chromosomes (A), 3F3/2 phosphoepitope (B), and microtubules (C). Bar, 5 I~m. 
3F3/2 epitope within the kinetochore, immunoelectron mi- 
croscopy was performed on Ptkl cells with the 3F3/2 anti- 
body. The kinetochore is a very dense complex, and pene- 
tration of such structures with large gold probes has been 
problematic (32). Thus, we elected to use secondary anti- 
bodies covalently linked to small, 1.4-nm gold particles fol- 
lowed by silver enhancement.  This combination resulted 
in good penetration of the kinetochore and dense, unmis- 
takable  labeling.  As  seen  in  Fig.  9,  the  3F3/2  phospho- 
epitope appears localized primarily to the middle, electron- 
lucent layer of the  trilaminar kinetochore  structure.  The 
distribution of silver particles was counted in ten electron 
micrographs  of labeled  kinetochores.  Some  62%  of the 
particles were found in the electron lucent middle zone of 
the kinetochore (Table II). 
Discussion 
Expression of the 3F312 Kinetochore 
Phosphoepitope Is Associated With the Activation of 
a Checkpoint That Blocks Anaphase Onset in the 
Presence of Misaligned Chromosomes 
In cells microinjected  with  the  3F3/2  antibody,  chromo- 
somes continued to express the phosphoepitope for an ex- 
tended  time after they reached the  metaphase plate. At 
the  same  time,  the  cells  were  inhibited  from  entering 
anaphase.  Only  after  a  significant  delay,  the  length  of 
which depended on the amount of antibody injected, did 
the  phosphoepitope  finally  disappear  from  the  kineto- 
chores of the  metaphase chromosomes.  Coincident  with 
the time of disappearance of the phosphoepitope, the cells 
overcame the metaphase block and entered anaphase. 
The  phosphoepitope  reappears  on  metaphase  kineto- 
chores  within  minutes  of treatment  with  nocodazole  or 
taxol, before disappearance of kinetochore microtubule fi- 
bers is detectable by light microscopy. Using electron mi- 
croscopy,  Cassimeris  et  al.  (5)  have  shown  that  kineto- 
chore microtubules completely disappear from Ptkl  cells 
Figure 9.  Ultrastructural  localization  of the  3F3/2 kinetochore 
phosphoepitope. The 3F3/2 epitope was labeled with 1.4-nm gold 
particles and then silver-enhanced,  resulting in a range of particle 
sizes. The silver particles are located primarily in the middle zone 
(arrows), between the inner and outer kinetochore plates.  Bar, 
0.1 txm. 
Table II. Distribution of Silver Particles in Electron 
Micrographs of 3F3/2 Antibody-labeled Kinetochores 
Outer plate 
Inner plate  Middle zone  and corona  Totals 
No. particles  107  686  314  1107 
% total  9.7  62  28.3  100 
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centration eight times greater than that used here. The re- 
suits  of our experiments with microtubule drugs suggest 
that the disruption of normal microtubule dynamics is suf- 
ficient to cause reexpression of the 3F3/2 phosphoepitope 
at metaphase kinetochores, even though they still contain 
many microtubules. This evidence suggests that simple oc- 
cupancy of the kinetochore by microtubules is not suffi- 
cient to signal a stable attachment and turn off the phos- 
phoepitope. 
In  mammalian  tissue  culture  cells  microinjection  of 
CREST autoimmune antibodies during interphase caused 
a metaphase arrest during the subsequent mitosis (3). In 
separate studies  using a  different source of CREST au- 
toimmune  IgG,  microinjection  of  antibody  into  mouse 
eggs  disrupted  chromosome  congression  when  injected 
during interphase or during early prometaphase in meiosis 
and  mitosis  (27).  The  microinjection  of  antibodies  to 
CENP-E,  a  kinesin-like  protein  found  at  kinetochores, 
was originally thought to arrest mammalian cells at meta- 
phase (35). However, recent studies have shown that anti- 
bodies to CENP-E have profound effects on the normal 
movement of chromosomes to the metaphase plate (Mol. 
Biol. Cell, 5 (suppl.):255a, abstract 1483). Thus, the 3F3/2 
antibody is unique in that, when injected during mitosis, it 
inhibits mitotic progression while allowing normal chro- 
mosome congression to the metaphase plate. 
Other treatments, such as the application of low concen- 
trations of microtubule inhibitors (12) or stabilizers (26), 
similarly lead to mitotic arrest with all the kinetochores 
and chromosomes aligned at a metaphase plate. These re- 
suits suggest that the mere positioning of kinetochores at 
the metaphase plate is not, by itself, sufficient to relieve 
the checkpoint preventing entry into anaphase. 
Finally,  although  expression  of  the  3F3/2  phospho- 
epitope at the mitotic poles diminishes only slightly from 
prometaphase to late anaphase  (10), we can not exclude 
the possibility that antibody binding at the poles plays a 
role in  the  induction  of the  metaphase  arrest.  Further- 
more,  it  is  also  possible  that  the  mechanism  of  the 
metaphase arrest caused by the antibody is more indirect, 
perhaps involving interference with kinetochore/microtu- 
bule interactions. 
Differential Expression of the 3F312 Phosphoepitope 
at Sister Kinetochores Is Not Essential  for Chromosome 
Movement to the Metaphase Plate 
Injection of the 3F3/2 antibody eliminated the asymmetric 
expression of the  phosphoepitope  on  the  sister  kineto- 
chores  of  moving  chromosomes  in  prometaphase.  Al- 
though we can not rule out very subtle effects, when com- 
paring control cells to those microinjected with the 3F3/2 
antibody, we found no differences in chromosome move- 
ment or in alignment at the metaphase plate. Therefore, 
we conclude that the 3F3/2 phosphoepitope is not likely to 
signal the activation or deactivation of kinetochore micro- 
tubule motors and does not play a direct role in regulating 
the directionality of chromosome movement. 
If not involved in regulating chromosome directionality, 
why is  the  phosphoepitope often expressed at  different 
levels on sister kinetochores? One explanation is that the 
difference in timing of sister kinetochore attachment to 
spindle microtubules is responsible for the asymmetric ex- 
pression of the 3F3/2 phosphoepitope (see Fig. 10). A  re- 
peat subunit model of kinetochore structure has been pro- 
posed wherein the kinetochore is composed of multiple 
functionally self-contained domains, each containing a mi- 
crotubule binding site (36). Stable attachment of a microtu- 
bule to the kinetochore might down-regulate 3F3/2 epitope 
expression in one subunit by locally turning off a kinase or 
activating  a  phosphatase.  Differential  expression of the 
phosphoepitope would be  expected on chromosomes in 
which each kinetochore was  attached to its pole by dif- 
ferent numbers of microtubules. Chromosomes mono-ori- 
ented to one pole begin to move toward the metaphase 
plate after capturing only one or a few microtubules from 
the opposite pole. Careful electron microscopic analysis of 
moving chromosomes should show that kinetochores ex- 
pressing intermediate levels of the phosphoepitope con- 
tain fewer microtubules than those in which 3F3/2 phos- 
phoepitope expression is absent. 
The 3F312 Phosphoepitope Resides on the 
Structural Connection Between the Inner and Outer 
Kinetochore Plates 
Using  computerized  reconstructions  of  thick  sections, 
McEwen  et  al.  (18)  proposed  a  model  of  kinetochore 
structure in which the outer, electron dense kinetochore 
plate, composed of a mat of intertwined 10-20-nm fibers, 
was connected to the inner plate by an array of connecting 
pillars. Our quantitative analysis revealed that the 3F3/2 
phosphoepitope is  located primarily in the middle, elec- 
tron-lucent, zone of the kinetochore, where these connect- 
ing structures are found. The protein in which the 3F3/2 
phosphoepitope resides may itself constitute, or be associ- 
ated with, a structural protein linking the inner and outer 
electron dense kinetochore plates. 
Linking Mechanical Signals at the Kinetochore and 
the Regulation of the 3F312 Phosphoepitope 
Dietz  (8)  first hypothesized that stable  chromosome at- 
tachment to the spindle is dependent upon proper tension, 
a hypothesis later verified by chromosome micromanipu- 
lation  studies  in  insect spermatocytes (2,  23).  McIntosh 
(19) proposed that a diffusible inhibitory signal from the 
kinetochores or centromeres of unattached chromosomes 
is  down regulated by microtubule-generated tension.  In 
meiotic mantid  spermatocytes, Li and Nicklas  (16)  have 
directly shown that tension, artificially placed on a  mal- 
oriented  chromosome,  induces  cells  with  a  misaligned 
chromosome to enter anaphase. 
We hypothesize that the mechanism detecting tension at 
the kinetochore or the system that broadcasts the signal 
controlling the progression of mitosis involves expression 
of the  3F3/2  phosphoepitope.  Skibbens  et  al.  (28)  have 
demonstrated that during prometaphase the kinetochore 
region undergoes stretching. The ultrastructural location 
of the  3F3/2  phosphoepitope  within  the  kinetochore is 
consistent with a role in sensing or responding to tension 
from the attached microtubules. 
The careful video analysis of Rieder et al. (26) suggests 
that stable attachment of microtubules to the last kineto- 
The Journal of Cell Biology, Volume 129, 1995  1202 Figure 10.  A model, based on the repeat subunit model of kinet- 
ochore structure, linking mechanical signals at the kinetochore to 
differential  expression of the 3F3/2 phosphoepitope. Often, one 
sister kinetochore of a chromosome attaches to spindle microtu- 
bules before the other (A).  Once bipolar attachment is estab- 
lished,  the chromosome begins  moving toward the  metaphase 
plate (B). At the same time, kinetochore subunits attached to mi- 
crotubules are subjected  to tension, which stretches those sub- 
units and initiates downregulation of the 3F3/2 kinetochore phos- 
phoepitope  (3F3/2  epitope  expression  is  represented  by  dark 
shading  in  the  kinetochore  subunits).  As  the  chromosome 
reaches  the  metaphase plate  (C),  all  kinetochore microtubule 
binding sites are occupied, the kinetochores are fully under ten- 
sion, and 3F3/2 epitope is absent. 
chore starts a  timer that counts down to anaphase onset. 
The time  delay provides  a  window for the  final  chromo- 
some,  after attachment to spindle  microtubules,  to move 
to the metaphase plate. We speculate that the slow decay 
of  the  3F3/2  phosphoepitope  from  the  kinetochores  of 
chromosomes as they move to the metaphase plate may be 
an early component of this timing mechanism. However, 
given that the 3F3/2 phosphoepitope is normally undetect- 
able  for some minutes before  anaphase  onset,  it may be 
that the decay of other, downstream elements of the path- 
way  is  more  proximally  responsible  for  finally  releasing 
the inhibition of anaphase onset. 
The  time  delay  between stable  attachment of the  final 
kinetochore and anaphase onset also provides a last qual- 
ity control check for accurate chromosome segregation. If, 
during this period, any kinetochores lose their normal at- 
tachment from the spindle microtubules, the timer must be 
reset. We suggest that the treatment of cells with microtu- 
bule  drugs  mimics  such  an  event.  Normal  kinetochore- 
microtubule  interactions  are  disrupted.  Immediately  the 
3F3/2 phosphoepitope  reappears  at the kinetochores and 
the checkpoint block is reestablished. 
When all the chromosomes are aligned at the metaphase 
plate  and  the  timer  has  run  out,  anaphase  is  initiated. 
Anaphase cells treated with nocodazole fail to regenerate 
the  3F3/2  phosphoepitope.  Thus  it  is  likely that the  ma- 
chinery  responsible  for  generating  the  3F3/2  phospho- 
epitope  at  kinetochores is  irreversibly  turned  off at  this 
transition. 
Due  to the  extreme  lability  of the phosphorylation in- 
volved,  the  identity  of the  kinetochore protein  that con- 
tains the 3F3/2 epitope is not yet known. However, the ex- 
periments presented here provide important evidence that 
the  phosphoepitope  plays  a  role  in  regulating  cell  cycle 
progression through mitosis. 
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